How Can Teachers Help Students in Online Classes?
Name
Capella University
NURS-FPX 6011 Evidence-Based Practice for Patient-Centered Care and Population Health
Prof. Name
Date
Type 2 diabetes presents a critical public health challenge in Riverside, where approximately 12% of adults are diagnosed with the condition, significantly above the national average. Socioeconomic disparities exacerbate the problem, as low-income residents often face significant barriers to accessing quality healthcare, including preventive and management services. The CDC reports that 38 million U.S. residents have diabetes, with 20% unaware of their condition, while over 98 million adults have undiagnosed prediabetes. Diabetes costs $413 billion annually in medical expenses and lost productivity (CDC, 2024). The high prevalence of Type 2 diabetes leads to severe complications such as cardiovascular disease, neuropathy, and chronic kidney disease, which not only diminish the quality of life but also impose substantial economic costs on the healthcare system (Farmaki et al., 2020). Effective management of Type 2 diabetes in Riverside requires a comprehensive approach that includes community-based interventions, targeted education, and improved access to care to mitigate these impacts and enhance patient outcomes.
In adults with Type 2 diabetes in Riverside (P), how does integrating telehealth services for diabetes management (I), compared to receiving standard in-person care (C), influence long-term health outcomes such as HbA1c reduction (O) over one year (T)?
This PICOT question is designed to assess whether integrating telehealth services into diabetes management can lead to improved long-term health outcomes, including reductions in HbA1c levels and enhancements in overall quality of life, compared to standard in-person care. By evaluating these outcomes over one year, the question seeks to determine the effectiveness of telehealth interventions in providing sustained benefits for diabetes patients.
The recommended practice change is the integration of a telehealth-based diabetes management program designed to address the needs of adults with Type 2 diabetes in Riverside. This program aims to combine telehealth technology with evidence-based practices to enhance the management of Type 2 diabetes. By incorporating remote consultations, virtual education, and continuous glucose monitoring, the program will provide personalized care plans tailored to individual patient needs. This approach seeks to improve glycemic control, enhance patient engagement, and overcome barriers associated with traditional in-person visits, such as transportation challenges and scheduling conflicts (Sharma et al., 2022). The ultimate goal is to reduce the burden of diabetes-related complications and improve the overall quality of life for individuals living with Type 2 diabetes.
The telehealth-based diabetes management program will be implemented over one year, targeting improvements for Type 2 diabetes patients. The first two months will focus on planning and preparation, forming a multidisciplinary team of endocrinologists, diabetes educators, IT specialists, and patient advocates. This team will conduct a needs assessment to identify gaps in Type 2 diabetes management and develop telehealth protocols. In months three and four, resource acquisition and staff training will be prioritized (Sharma et al., 2022). This includes acquiring a telehealth platform and remote monitoring devices and training healthcare providers on using these technologies for remote Type 2 diabetes management.
Months five and six will see the launch of a pilot telehealth program with selected Type 2 diabetes patients, monitoring key metrics such as HbA1c reduction, treatment adherence, and patient satisfaction (Groot et al., 2021). Feedback from the pilot will refine the program. From months seven to nine, the program will expand to all eligible Type 2 diabetes patients in Riverside, with ongoing monitoring and support to ensure effectiveness. The final three months will involve a comprehensive evaluation of the telehealth program’s impact on clinical outcomes and patient quality of life, guiding further refinements and optimization.
Several vital tools and resources are essential to effectively implementing the telehealth-based diabetes management program for Type 2 diabetes. A secure and robust telehealth platform is required for virtual consultations, managing patient data, and ensuring confidentiality, with capabilities to integrate with diabetes management systems for real-time glucose monitoring and updates (Phillip et al., 2020). Remote monitoring devices, including continuous glucose monitors, are crucial for accurate, timely data on blood glucose levels, allowing patients to manage their HbA1c from home and enabling tailored treatment plans (Johnson & Miller, 2022). Comprehensive training materials and programs are needed to equip healthcare providers with the skills to use telehealth technologies and engage patients effectively. Patient education resources, such as detailed brochures, online learning modules, and interactive tools, will support understanding of the condition, lifestyle modifications, medication management, and HbA1c reduction control strategies (Lara et al., 2020). Additionally, a data management system is essential for tracking patient outcomes, analyzing program effectiveness, and supporting ongoing quality improvement.
The telehealth-based diabetes management program for Type 2 diabetes in Riverside will impact several stakeholders. Patients will benefit from improved access to care through telehealth virtual consultations and continuous monitoring, enhancing their condition management. Healthcare providers, including endocrinologists and diabetes educators, must adapt to delivering care remotely for HbA1c reduction, requiring proficiency with telehealth technologies (Isaacs et al., 2020). Administrative and IT staff will manage and support the telehealth infrastructure, ensuring its effective operation. Healthcare organizations will need to integrate telehealth into existing workflows, necessitating process adjustments (Horton et al., 2020). Insurance providers will update policies to cover telehealth services comprehensively. Policymakers and regulators will ensure that the telehealth program adheres to healthcare regulations and maintains quality standards.
The telehealth project planned for Type 2 diabetes in Riverside offers several innovative opportunities. Remote monitoring devices, such as continuous glucose monitors (CGMs) and wearable trackers, will provide real-time data on glucose levels and HbA1c reduction and activity through telehealth platforms, enabling precise treatment adjustments (Leon et al., 2020). Telehealth platforms will facilitate secure video consultations, allowing patients to interact with providers from home and overcome geographical barriers. Mobile health (mHealth) apps will feature glucose logging, medication reminders, and educational resources, enhancing patient engagement in telehealth (Yin et al., 2020). Integration with electronic health records (EHR) systems will centralize patient data through telehealth, improving care coordination and HbA1c reduction. Secure messaging systems will enable asynchronous communication for timely responses in telehealth (Wiley et al., 2022). Virtual education programs will deliver essential diabetes management information remotely through telehealth, including dietary and exercise guidance.
Implementing telehealth for Type 2 diabetes involves overcoming several barriers. Remote monitoring devices may face challenges with usage consistency and data accuracy, necessitating thorough patient training. Telehealth consultations might encounter issues with patient engagement and technical problems, affecting care quality (Yin et al., 2020). Mobile health apps could need help with user adoption and proficiency, requiring user-friendly design and support. EHR integration may present difficulties with data interoperability, while secure messaging systems could face issues with response timeliness and patient privacy, demanding robust system maintenance and user education (Wiley et al., 2022). Additionally, virtual education programs may only reach some patients due to technology access issues, highlighting the need for alternative educational methods.
The effectiveness of the telehealth-based diabetes management program for Type 2 diabetes in Riverside will be evaluated using specific outcome criteria. First, clinical outcomes will be measured by tracking changes in patients’ HbA1c levels, with a particular focus on HbA1c reduction as a primary indicator of successful diabetes management. A significant reduction in HbA1c levels will reflect improved blood glucose control and the effectiveness of the telehealth interventions (Zhang et al., 2022). Additionally, the frequency of diabetes-related complications will be monitored to assess overall health improvements. Patient engagement will be evaluated through metrics such as the frequency of telehealth appointments, the usage rates of mobile health (mHealth) apps, and participation in virtual education programs (Robson & Hosseinzadeh, 2021). Patient satisfaction will be assessed through surveys and feedback forms, focusing on patients’ experiences with telehealth consultations, technology usability, and overall satisfaction with care. Healthcare provider satisfaction will be measured by evaluating providers’ ease of use with telehealth platforms, perceived effectiveness of remote care, and overall job satisfaction (Sim & Lee, 2021). Cost-effectiveness will be assessed by comparing the costs of telehealth services with traditional in-person care, including reductions in hospital admissions and emergency room visits.
The outcomes of the telehealth-based diabetes management project align with the Quadruple Aim, which includes improving patient experience, enhancing population health, reducing costs, and improving the work life of healthcare providers. Improving patient experience is directly addressed by enhancing access to care through telehealth, providing timely and convenient consultations, and offering educational resources that empower patients to manage their diabetes more effectively (Sim & Lee, 2021). Enhancing population health is supported by the use of remote monitoring and telehealth education, which can lead to better management of Type 2 diabetes and notable HbA1c reduction across the Riverside community.
Effective telehealth interventions are expected to achieve significant HbA1c reductions, improving overall metabolic control and reducing the risk of diabetes-related complications (Groot et al., 2021). Lowering costs is targeted by minimizing the need for in-person visits and hospitalizations through effective remote management and early intervention, potentially lowering overall healthcare expenditures. Improving the work life of healthcare providers is achieved by integrating user-friendly telehealth technologies that streamline workflows and reduce the administrative burden associated with in-person appointments (Haleem et al., 2021). These outcome criteria ensure that the telehealth-based diabetes management program is evaluated comprehensively, aligning with the goals of the Quadruple Aim to enhance overall healthcare delivery and improve patient outcomes.
To evaluate the evidence supporting the need for a practice change in managing Type 2 diabetes within Riverside, a thorough search strategy was employed. The search involved querying multiple academic databases, including PubMed, CINAHL, and Cochrane Library. Relevant keywords and phrases such as “Type 2 diabetes management,” “telehealth interventions,” “HbA1c reduction,” and “evidence-based practice in diabetes” were utilized. Boolean operators (AND, OR) were applied to refine the search results, ensuring the inclusion of pertinent studies and reviews. The search was restricted to articles published within the last five years to ensure the relevance and timeliness of the evidence.
The search identified a robust body of evidence supporting telehealth interventions for Type 2 diabetes management. Studies consistently demonstrate that telehealth can significantly improve diabetes management, with a meta-analysis revealing an average HbA1c reduction of 0.5% to 1%. Telehealth tools, such as mobile health (mHealth) apps and wearable devices, have been shown to enhance patient engagement, leading to better adherence to treatment and healthier lifestyle choices (Robson & Hosseinzadeh, 2021). Additionally, evidence indicates that telehealth interventions are cost-effective, reducing healthcare expenses by up to 20% due to fewer in-person visits and hospitalizations. Patients report higher satisfaction with telehealth compared to traditional care, and providers note improved patient outcomes and better management of chronic conditions (Sim & Lee, 2021). Despite the high quality of most studies, some had limitations like small sample sizes and short follow-up periods, which could affect the generalizability of the findings. Overall, the evidence strongly supports integrating telehealth into Type 2 diabetes management in Riverside to improve patient outcomes and healthcare efficiency.
The proposed telehealth-based diabetes management program for Riverside aims to address the high prevalence of Type 2 diabetes through remote consultations, continuous monitoring, and virtual education. This comprehensive approach is expected to improve long-term health outcomes, including significant HbA1c reduction, by enhancing patient engagement and overcoming barriers to in-person care. By aligning with the Quadruple Aim, improving patient experience, enhancing population health, reducing costs, and improving provider work life, the program promises to be a cost-effective and patient-centered solution. The plan’s success will be measured through clinical outcomes, patient and provider satisfaction, and overall cost-effectiveness, ensuring a significant impact on both individual health and the healthcare system.
CDC. (2024). A Report Card: Diabetes in the United States. Diabetes. https://www.cdc.gov/diabetes/communication-resources/diabetes-statistics.html
Farmaki, P., Damaskos, C., Garmpis, N., Garmpi, A., Savvanis, S., & Diamantis, E. (2020). Complications of type 2 diabetes mellitus. Current Cardiology Reviews, 16(4), 249–251. https://doi.org/10.2174/1573403×1604201229115531
Groot, J. D., Wu, D., Flynn, D., Robertson, D., Grant, G., & Sun, J. (2021). Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis. World Journal of Diabetes, 12(2), 170–197. https://doi.org/10.4239/wjd.v12.i2.170
Haleem, A., Javaid, M., Singh, R. P., & Suman, R. (2021). Telemedicine for healthcare: Capabilities, features, barriers, and applications. Sensors International, 2(2). NCBI. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590973/
Horton, M. B., Brady, C. J., Cavallerano, J., Abramoff, M., Barker, G., Chiang, M. F., Crockett, C. H., Garg, S., Karth, P., Liu, Y., Newman, C. D., Rathi, S., Sheth, V., Silva, P., Stebbins, K., & Zimmer-Galler, I. (2020). Practice guidelines for ocular telehealth-diabetic retinopathy. Telemedicine and E-Health, 26(4), 495–543. https://doi.org/10.1089/tmj.2020.0006
Isaacs, D., Cox, C., Schwab, K., Oser, T. K., Rinker, J., Mason, M. J., Greenwood, D. A., & Albanese-O’Neill, A. (2020). Technology integration: The role of the diabetes care and education specialist in practice. The Diabetes Educator, 46(4), 323–334. https://doi.org/10.1177/0145721720935123
Johnson, E. L., & Miller, E. (2022). Remote patient monitoring in diabetes: How to acquire, manage, and use all of the data. Diabetes Spectrum, 35(1), 43–56. https://doi.org/10.2337/dsi21-0015
Joyce, P. (2021). Digital treatment technologies and remote patient monitoring in diabetes nurse’s work. Theseus.fi. http://www.theseus.fi/handle/10024/494539
Lara, T. R., Muñoz, V., Salmerón, G. M., Damián, D., Bravo, P. M., García, I. R., & López, L. V. (2020). Education with a multimedia web platform improves knowledge and HbA1c of Mexican patients with type 2 diabetes. Open clinical trial. Endocrinología, Diabetes Y Nutrición (English Edition), 67(8), 530–539. https://doi.org/10.1016/j.endien.2019.07.007
Leon, C. R., Villalonga, C., Torres, M. M., Ruiz, J. R., & Banos, O. (2020). Mobile and wearable sensing for the monitoring of diabetes-related parameters: systematic review (Preprint). JMIR MHealth and UHealth, 9(6). https://doi.org/10.2196/25138
Phillip, M., Bergenstal, R. M., Close, K. L., Danne, T., Garg, S., Heinemann, L., Hirsch, I. B., Kovatchev, B., Laffel, L. M., Mohan, V., Parkin, C. G., & Battelino, T. (2020). The digital/virtual diabetes clinic: The future is now—recommendations from an international panel on diabetes digital technologies introduction. Diabetes Technology & Therapeutics, 23(2). https://doi.org/10.1089/dia.2020.0375
Robson, N., & Hosseinzadeh, H. (2021). Impact of telehealth care among adults living with type 2 diabetes in primary care: A systematic review and meta-analysis of randomised controlled trials. International Journal of Environmental Research and Public Health, 18(22), 12171. https://doi.org/10.3390/ijerph182212171
Sharma, V., Feldman, M., & Sharma, R. (2022). Telehealth technologies in diabetes self-management and education. Journal of Diabetes Science and Technology, 18(1), 193229682210930. https://doi.org/10.1177/19322968221093078
Sim, R., & Lee, S. W. H. (2021). Patient preference and satisfaction with the use of telemedicine for glycemic control in patients with type 2 diabetes: A review. Patient Preference and Adherence, 15, 283–298. https://doi.org/10.2147/ppa.s271449
Wiley, K. K., Mendonca, E., Blackburn, J., Menachemi, N., Ye, W., & Vest, J. R. (2022). Quantifying electronic health record data quality in telehealth and office-based diabetes care. Applied Clinical Informatics, 13(05), 1172–1180. https://doi.org/10.1055/s-0042-1758737
Yin, Z., Lesser, J., Paiva, K. A., Zapata Jr, J., Vasquez, A. M., Grigsby, T. J., Pettes, S. R. R., Medina, D. P., Estrada, V., Li, S., & Wang, J. (2020). Using mobile health tools to engage rural underserved individuals in a diabetes education program in south Texas: Feasibility study. JMIR MHealth and UHealth, 8(3), e16683. https://doi.org/10.2196/16683
Zhang, A., Wang, J., Wan, X., Zhang, Z., Zhao, S., Guo, Z., & Wang, C. (2022). A meta-analysis of the effectiveness of telemedicine in glycemic management among patients with type 2 diabetes in primary care. International Journal of Environmental Research and Public Health, 19(7), 4173. https://doi.org/10.3390/ijerph19074173
Have a question or need support? Connect with our team today. We’re ready to assist you with personalized guidance to help you achieve your academic goals. Reach out via email, phone, or our easy-to-use contact form.
612-217-0144
info@hireonlineclasshelp.com
Get expert assistance to excel in your courses with personalized support. Our creative approach ensures your academic success every step of the way.
Our Services
